MiRNA can be used as a biomarker to predict disease recurrence and mortality in breast cancer patients
Researchers at the University of Galway have found that biomarkers known as microRNAs can help predict which breast cancer patients are likely to face disease recurrence and death. Scientists led by Dr. Matthew Davey, Professor Michael Kerin and Dr. Nicola Miller of the University’s College of Medicine, Nursing and Health Sciences conducted a multicentre study …